Home › Atherosclerosis › Alabama
Atherosclerosis clinical trials in Alabama
6 studies for Atherosclerosis are looking for participants at sites in Alabama.
Cities in Alabama
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 5, 2026 · NCT07521007A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07783802Polygenic Risk Score Implementation and Stratification for Managing Blood Pressure
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 to 55 · All sexes · Updated Oct 9, 2026 · NCT06962488Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- Birmingham Clinical Research, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Nephrology of North Alabama, Decatur
- Nephrology Consultants, LLC, Huntsville
- DaVita Clinical Research Montgomery, Montgomery
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Athens
- Research Site, Birmingham
- Research Site, Birmingham
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.